Drug Trial Radar · NCT07282743
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
Last checked: Nov 19, 2026Latest source record: Mar 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
285
Planned (sponsor's estimate)
Start
Jan 20, 2026
Primary completion
Apr 2027
Study completion Aug 2027
Sponsor
- Lead sponsor
- Sun Pharmaceutical Industries LimitedIndustry
- Sponsor type
- Industry
- First posted
- Dec 15, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase II, randomized, double-blind, placebo-controlled study to evaluate the efficacy and tolerability of GL0034 among type II diabetes mellitus subjects who are obese or overweight with weight-related comorbidities. Subjects will be put on either one of the four treatment arms (GL0034, once a week, subcutaneous injection) or placebo arm (once a week, subcutaneous injection) following initial dose-up titration that takes up to approximately 20 weeks. The primary end point is change in HbA1c levels from baseline (Week 0) to Week 36 following treatments in all participants.
Conditions
- Type II Diabetes Mellitus
Interventions
GL0034 Dose Level 1Drug
Dose 1, once a week
GL0034 Dose Level 2Drug
Dose 2, once a week
GL0034 Dose Level 3Drug
Dose 3, once a week
GL0034 Dose Level 4Drug
Dose 4, once a week
GL0034 Dose Level 5Drug
Dose 5, once a week
GL0034 Dose Level 6Drug
Dose 6, once a week
PlaceboOther
Placebo, once a week
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in HbA1c levels from baseline (Week 0) to Week 36 following treatments in all participantsTime frame: Week 36
Locations
21 sites in 2 countries. Site status is shown where the registry gives one.
Lynn Institute of the Ozarks
Little Rock, Arkansas · Recruiting
Family First Medical Research Center
Hialeah Gardens, Florida · Recruiting
Alliance for Multispecialty Research (AMR Clinical) - Wichita East
Lakeland, Florida · Recruiting
CNS Healthcare - Memphis (Clinical Neuroscience Solutions - Memphis)
Lakeland, Florida · Recruiting
GTL Medical & Research Group
Miami, Florida · Recruiting
Florida Institute for Clinical Research LLC
Orlando, Florida · Recruiting
AMR Clinical, El Dorado
El Dorado, Kansas · Recruiting
AMR Clinical - Newton
Newton, Kansas · Recruiting
Lynn Health Science Institute - Oklahoma City
Oklahoma City, Oklahoma · Recruiting
Endolife Specialty Hospitals Pvt. Ltd.
Guntur, Andhra Pradesh, India · Recruiting
Life Care Hospital and Research Centre
Bangalore, Karnataka, India · Recruiting
Government Medical College
Kozhikode, Kerala, India · Recruiting
Jothydevs Diabetes Research Centre
Trivandrum, Kerala, India · Recruiting
Nirmal Hospital Private Limited
Kolhāpur, Maharashtra, India · Recruiting
Topiwala National Medical College & BYL Nair Hospital
Mumbai, Maharashtra, India · Recruiting
Seth G. S. medical college and KEM hospital
Mumbai, Maharashtra, India · Recruiting
BSES Municipal General Hospital
Mumbai, Maharashtra, India · Recruiting
LMMF's Deenanath Mangeshkar Hospital and Research Center
Pune, Maharashtra, India · Recruiting
Lady Hardinge Medical College and S.S.K. Hospital
New Delhi, National Capital Territory of Delhi, India · Recruiting
All India Institute of Medical Sciences
New Delhi, National Capital Territory of Delhi, India · Recruiting
Madras Diabetes Research Foundation (MDRF)
Chennai, Tamil Nadu, India · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.